An additional five University of Maryland School of Pharmacy (UMSOP) faculty, postdoctoral fellows, and graduate students have received University of Maryland Strategic Partnership: MPowering the State Early Scholars Investment Fund Awards, bringing the school’s total number of awardees in 2026 to seven.
In its first two rounds of funding in 2026, MPower has awarded nearly $1.3 million to 29 early-career researchers across the University of Maryland, Baltimore, supporting scholars whose work was impacted by cuts to federal research funding.
Among the UMSOP awardees are investigators working at the intersection of basic science, drug development, and clinical impact. Their projects span antiviral discovery, immunotherapy, antimicrobial resistance, and mental health – underscoring the range of challenges being addressed within UMSOP research.
Read the full story at the School of Pharmacy's News Center.